257 related articles for article (PubMed ID: 28425821)
1. L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.
Maldonado C; Guevara N; Silveira A; Fagiolino P; Vázquez M
J Int Med Res; 2017 Jun; 45(3):1268-1272. PubMed ID: 28425821
[TBL] [Abstract][Full Text] [Related]
2. Quantitative systems pharmacology Model to characterize valproic acid-induced hyperammonemia and the effect of L-carnitine supplementation.
Schiavo A; Maldonado C; Vázquez M; Fagiolino P; Trocóniz IF; Ibarra M
Eur J Pharm Sci; 2023 Apr; 183():106399. PubMed ID: 36740101
[TBL] [Abstract][Full Text] [Related]
3. Carnitine in the treatment of valproic acid-induced toxicity.
Lheureux PE; Hantson P
Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
[TBL] [Abstract][Full Text] [Related]
4. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
Hamed SA; Abdella MM
Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
[TBL] [Abstract][Full Text] [Related]
5. Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.
Cattaneo CI; Ressico F; Valsesia R; D'Innella P; Ballabio M; Fornaro M
Medicine (Baltimore); 2017 Sep; 96(39):e8117. PubMed ID: 28953637
[TBL] [Abstract][Full Text] [Related]
6. Two cases of valproic acid poisoning treated with L-carnitine.
Chan YC; Tse ML; Lau FL
Hum Exp Toxicol; 2007 Dec; 26(12):967-9. PubMed ID: 18375641
[TBL] [Abstract][Full Text] [Related]
7. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.
Verrotti A; Greco R; Morgese G; Chiarelli F
Int J Clin Lab Res; 1999; 29(1):36-40. PubMed ID: 10356662
[TBL] [Abstract][Full Text] [Related]
8. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy.
Mock CM; Schwetschenau KH
Am J Health Syst Pharm; 2012 Jan; 69(1):35-9. PubMed ID: 22180549
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid-induced hyperammonemia: a case report.
McCall M; Bourgeois JA
J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
[TBL] [Abstract][Full Text] [Related]
10. Carnitine supplementation for valproate-related hyperammonemia to maintain therapeutic valproate level.
Sonik P; Hilty DM; Rossaro L; Bourgeois JA
J Clin Psychopharmacol; 2011 Oct; 31(5):680-2. PubMed ID: 21881462
[No Abstract] [Full Text] [Related]
11. The role of carnitine supplementation during valproic acid therapy.
Raskind JY; El-Chaar GM
Ann Pharmacother; 2000 May; 34(5):630-8. PubMed ID: 10852092
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia associated with valproic acid concentrations.
Vázquez M; Fagiolino P; Maldonado C; Olmos I; Ibarra M; Alvariza S; Guevara N; Magallanes L; Olano I
Biomed Res Int; 2014; 2014():217269. PubMed ID: 24868521
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
Mallet L; Babin S; Morais JA
Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
[TBL] [Abstract][Full Text] [Related]
14. Severe acute hyperammonemia after brief exposure to valproate.
Eubanks AL; Aguirre B; Bourgeois JA
Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182
[TBL] [Abstract][Full Text] [Related]
15. L-carnitine supplementation as a potential therapy for suspected hyperammonaemic encephalopathy.
Khakwani A; Gannon D
J R Coll Physicians Edinb; 2019 Dec; 49(4):301-303. PubMed ID: 31808457
[TBL] [Abstract][Full Text] [Related]
16. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.
Barrueto F; Hack JB
Acad Emerg Med; 2001 Oct; 8(10):999-1001. PubMed ID: 11581089
[TBL] [Abstract][Full Text] [Related]
17. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center.
Glatstein M; Bonifacio Rino P; de Pinho S; Scolnik D; Pivko-Levi D; Hoyte C
Am J Ther; 2019; 26(3):e344-e349. PubMed ID: 29232283
[TBL] [Abstract][Full Text] [Related]
18. L-Arginine in the treatment of valproate overdose - five clinical cases.
Schrettl V; Felgenhauer N; Rabe C; Fernando M; Eyer F
Clin Toxicol (Phila); 2017 Apr; 55(4):260-266. PubMed ID: 28152637
[TBL] [Abstract][Full Text] [Related]
19. Differential ammonia decay kinetics indicates more than one concurrent etiological mechanism for symptomatic hyperammonemia caused by valproate overdose.
Mojumder DK; De Oleo RR
Indian J Pharmacol; 2014; 46(3):345-7. PubMed ID: 24987188
[TBL] [Abstract][Full Text] [Related]
20. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.
Ohtani Y; Endo F; Matsuda I
J Pediatr; 1982 Nov; 101(5):782-5. PubMed ID: 6813444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
